Impact of Belly Board on small bowel toxicity in carcinoma cervix
Phase 3
Completed
- Conditions
- Health Condition 1: C539- Malignant neoplasm of cervix uteri, unspecified
- Registration Number
- CTRI/2020/10/028235
- Lead Sponsor
- SVIMS
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 28
Inclusion Criteria
1)Biopsy proven cervix carcinoma patients.
2)ECOG performance status 0-2.
3)FIGO stage IB2 to IIIC1.
4)Patients who are willing to give consent.
Exclusion Criteria
1)Patients who took radiation previously to pelvis & abdomen.
2)FIGO stages IA,IB1,IIIC2,IVA with VVF.
3)Patients with known distant metastasis.
4)Patients with ECOG status 3-4.
5)Pregnant and lactating mothers.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Acute toxicitiesTimepoint: weekly during RT
- Secondary Outcome Measures
Name Time Method Acute toxcitiesTimepoint: Monthly after RT